Adverse Events During Dosing of Delayed-Release/Extended Release Methylphenidate – Learnings from the Open-Label Phase of a Registration Trial and a Real-World Post-Marketing Surveillance Program
Martin A. Katzman, BSc, MD, FRCPC; Victor Otcheretko, MD,; Michelle D. Po, PhD,; Cassandra L. Uchida, PhD; Bev Incledon, PhD
